INNOVATION PHARMACEUTICAL (IPIX) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 127 231 sessions, October 1, 2025 to October 1, 2026
- Largest daily move
- +2900% close of May 1, 2026
- 1-year change
- -93.3% closing prices, October 1, 2025 to October 1, 2026
- 1-month change
- -86.7% closing prices, August 28, 2026 to October 1, 2026
Company Description
INNOVATION PHARMACEUTICAL (OTC: IPIX) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $1.0M.
IPIX has declined 93.3% over the past year. The last closing price was $0.0002.
For FY2023, INNOVATION PHARMACEUTICAL reported revenue of $0 with net income of -$3.2M.
This page collects what Stock Titan holds for IPIX, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
INNOVATION PHARMACEUTICAL (IPIX) closed at $0.0002 on October 1, 2026. Over the past 12 months, the price has lost 93.3%.
IPIX Metrics & Rankings
Price returns through October 1, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
INNOVATION PHARMACEUTICAL has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 3 with negative movement. Key topics include fda approval, clinical trial. View all IPIX news →
SEC Filings
Financial Highlights
operating income reached -$3.1M, and net income was -$3.2M. The company generated -$2.1M in operating cash flow. The current ratio was 0.33, measuring current assets divided by current liabilities.
Upcoming Events
Short Interest History
Days to Cover History
IPIX Company Profile & Sector Positioning
INNOVATION PHARMACEUTICAL (IPIX) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing IPIX often look at related companies in the same sector, including PSYBIO THERAPEAUTICS CORP (PSYBF), BRAXIA SCIENTIFIC CORP (BRAXF), Biora Therapeutics, Inc. (BIOR), YULONG ECO MATERIALS LTD (YECO), and REGEN BIOPHARMA PFD A (RGBPP). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate IPIX's relative position within its industry.